Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Saved in:
| Title: | Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy. |
|---|---|
| Authors: | Martin, Nikolas T.1,2 (AUTHOR), Crupi, Mathieu J. F.1,2 (AUTHOR), Taha, Zaid1,2 (AUTHOR), Poutou, Joanna1,2 (AUTHOR), Whelan, Jack T.1,2 (AUTHOR), Vallati, Sydney1,2 (AUTHOR), Petryk, Julia1 (AUTHOR), Marius, Ricardo1 (AUTHOR), Austin, Bradley1 (AUTHOR), Azad, Taha1,2 (AUTHOR), Boulanger, Mason1 (AUTHOR), Burgess, Tamara1 (AUTHOR), Sanders, Ilson1 (AUTHOR), Victoor, Camille1 (AUTHOR), Dickinson, Bryan C.3 (AUTHOR), Diallo, Jean-Simon1,2 (AUTHOR), Ilkow, Carolina S.1,2 (AUTHOR), Bell, John C.1,2 (AUTHOR) jbell@ohri.ca |
| Source: | Pharmaceuticals (14248247). May2023, Vol. 16 Issue 5, p709. 23p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14248247 |
|---|---|
| DOI: | 10.3390/ph16050709 |
